SPDR S&P Biotech ETF (XBI) saw an approximate $234.1M outflow week over week, a 2.1% decline in shares outstanding. This suggests mild risk-off positioning toward biotech exposure rather than a company-specific fundamental catalyst.
SPDR S&P Biotech ETF (XBI) saw an approximate $234.1M outflow week over week, a 2.1% decline in shares outstanding. This suggests mild risk-off positioning toward biotech exposure rather than a company-specific fundamental catalyst.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request DemoOverall Sentiment
mildly negative
Sentiment Score
-0.20
Ticker Sentiment
